Taken together, we speculate that, probably, lncRNA CASC8 rs10505477 polymorphism could affect the efficacy and toxicity of platinum-based chemotherapeutic drugs through POU5F1B-OCT-3/4-ABCG2 axis in lung cancer patients. The gene discussed is CASC8; the disease is lung cancer.